Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of MRI Prostate in Improving Detection of Significant Prostate Cancer in a Screening Population of Chinese Men With Elevated PSA

NCT03891732 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03891732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of MRI Prostate in Improving Detection of Significant Prostate Cancer in a Screening Population of Chinese Men With Elevated PSA
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Active, not recruiting
Start date
January 19, 2019
Completion date
December 31, 2024
Enrollment
690 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mri, prostate cancer, psa